Bayer / cardinal RA-223 xofigo RX injections

Ended Awarded

Contract number
36C26020N0156
Awardee
Awarding agency
Obligated
$292,836

Award facts

Opportunity
  • 36C26019AP5571 Solicitation number
Contract value 100% obligated
$292,836.43 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Wayne, NJ, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Modification $356,355
Other Administrative Action P00001 $0
Other Administrative Action P00002 -$63,519

About this award

This is a firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned for-profit pharmaceutical company. The order is for the supply of Xofigo (radium Ra 223 dichloride) injections, a prostate cancer treatment, to VA facilities. The award has a potential value of $292,836.43 and covers the period from November 1, 2019 to October 31, 2020. The contract was made under the VA's Pharmaceutical and Drugs Federal Supply Schedule (FSS-61-IB), which enables rapid procurement of essential medical products for veterans. No small business set-aside was used for this award. Bayer Healthcare Pharmaceuticals Inc. has previously supplied specialty pharmaceuticals, including anticoagulants, pulmonary hypertension treatments, and other medical products, to the VA and the Defense Logistics Agency through FSS contracts and IDIQs.

Quick answers

Who was awarded contract 36C26020N0156?

36C26020N0156 was awarded to Bayer Healthcare Pharmaceuticals Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on November 1, 2019.

How much is contract 36C26020N0156 worth?

The government has obligated $292,836 on 36C26020N0156.

Is contract 36C26020N0156 an order under another contract?

Yes. 36C26020N0156 is a delivery order under V797P2202D, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26020N0156 competed?

The extent of competition for 36C26020N0156 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award